PharmaShots | Incisive News in 3 Shots

Subscribe Now

Phenylketonuria

BioMarin Reports FDA's Hold on P-I/II Phearless Trial of BMN 307 in Adults with PKU

BioMarin Reports FDA's Hold on P-I/II Phearless Trial of BMN 307 in Adults with PKU

September 6, 2021

BioMarin Receives the US FDA's Approval Allowing Maximum Dose of 60mg with Palynziq (pegvaliase-pqpz) for PKU

BioMarin Receives the US FDA's Approval Allowing Maximum Dose of 60mg with Palynziq (pegvaliase-pqpz) for PKU

October 8, 2020

BioMarin's Palynziq (pegvaliase injection) Receives European Commission's MAA Approval for Phenylketonuria

BioMarin's Palynziq (pegvaliase injection) Receives European Commission's MAA Approval for Phenylketonuria

May 7, 2019

BioMarin's Palynziq (pegvaliase-pqpz) Receives FDA Approval for Phenylketonuria (PKU) in Adults

BioMarin's Palynziq (pegvaliase-pqpz) Receives FDA Approval for Phenylketonuria (PKU) in Adults

May 24, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us